Oramed Pharmaceuticals
ORMP
ORMP
35 hedge funds and large institutions have $4.73M invested in Oramed Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
13% more funds holding
Funds holding: 31 → 35 (+4)
3.03% more ownership
Funds ownership: 2.77% → 5.8% (+3%)
Holders
35
Holding in Top 10
–
Calls
$584K
Puts
$335K
Top Buyers
| 1 | +$1.35M | |
| 2 | +$610K | |
| 3 | +$317K | |
| 4 |
Renaissance Technologies
New York
|
+$127K |
| 5 |
LP
LMR Partners
London,
United Kingdom
|
+$116K |
Top Sellers
| 1 | -$119K | |
| 2 | -$103K | |
| 3 | -$40K | |
| 4 |
BFM
Boothbay Fund Management
New York
|
-$21.5K |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
-$20K |